CIK 0001651308 · Large accelerated filer
BeOne Medicines Ltd.
Sign in to watch- Ticker
- BEIGF
- Exchange
- Nasdaq, OTC
- Industry
- Pharmaceutical Preparations
- FY end
- Dec 31
- Entity type
- operating
- EIN
- 981209416
- Phone
- 41-616851900
- Business address
- C/O BEONE MEDICINES I GMBH, AESCHENGRABEN 27, 21ST FLOOR, BASEL, Switzerland, 4051
- Former names
- BeiGene, Ltd.
Securities
- ONC American Depositary Shares Nasdaq
- BEIGF Common stock OTC
- Open-market buys, last 90 days
- $0
- in 0 filings
- Open-market sales, last 90 days
- $48,487,541
- in 9 filings, $47.8M under 10b5-1 plans
Net −$48,487,541. Shares bought or sold at a price by officers, directors and 10% owners (Form 4 codes P and S). Grants, option exercises and tax withholding aren't counted.
Who's trading
90 days
Reading 100 more Form 4s from the SEC; this list fills in as they're read.
| Date | Insider | Transaction | Shares | Price | Value | Owned after |
|---|---|---|---|---|---|---|
| 2020-12-10 | Wang Xiaodong Director | Gift | +1,244,542 | 1,244,542 | ||
| 2020-12-04 | Glazer Donald W. Director | Gift | −589,849 | 2,907,829 | ||
| 2020-12-04 | BAKER BROS. ADVISORS LP Director | Sale | −125,513 | $220.50 | $27.7M | 979,003 |
| 2020-12-04 | BAKER BROS. ADVISORS LP Director | Sale | −1,386,033 | $220.50 | $305.6M | 10,811,048 |
| 2020-11-30 | Huang Jane CMO, Hematology | Option exercise | +1,500 | $29.49 | $44K | 1,500 |
| 2020-11-30 | Huang Jane CMO, Hematology | Sale | −104 | $256.00 | $27K | 1,396 |
| 2020-11-30 | Huang Jane CMO, Hematology | Sale | −100 | $260.06 | $26K | 1,296 |
| 2020-11-30 | Huang Jane CMO, Hematology | Sale | −200 | $262.06 | $52K | 1,096 |
| 2020-11-30 | Huang Jane CMO, Hematology | Sale | −100 | $263.28 | $26K | 996 |
| 2020-11-30 | Huang Jane CMO, Hematology | Sale | −200 | $264.50 | $53K | 796 |
| 2020-11-30 | Huang Jane CMO, Hematology | Sale | −300 | $266.75 | $80K | 496 |
| 2020-11-30 | Huang Jane CMO, Hematology | Sale | −100 | $269.05 | $27K | 396 |
| 2020-11-30 | Huang Jane CMO, Hematology | Sale | −100 | $275.45 | $28K | 296 |
| 2020-11-30 | Huang Jane CMO, Hematology | Sale | −100 | $277.22 | $28K | 196 |
| 2020-11-30 | Huang Jane CMO, Hematology | Sale | −100 | $278.92 | $28K | 96 |
| 2020-11-30 | Huang Jane CMO, Hematology | Sale | −96 | $285.05 | $27K | 0 |
| 2020-11-30 | Huang Jane CMO, Hematology | Option exercise · Share Option (Right to Buy) | −19,500 | 344,075 | ||
| 2020-10-29 | Huang Jane CMO, Hematology | Option exercise | +1,500 | $29.49 | $44K | 1,500 |
| 2020-10-29 | Huang Jane CMO, Hematology | Sale | −1,261 | $299.88 | $378K | 239 |
| 2020-10-29 | Huang Jane CMO, Hematology | Sale | −139 | $300.70 | $42K | 100 |
Page 76 of 99 · 1,972 trades